Kazakhstan’s largest pharmaceutical company talks digitalization projects (Exclusive)
Baku, Azerbaijan, October 1
By Nargiz Sadikhova - Trend:
Existing capacities of Kazakhstan’s largest pharmaceutical company SANTO allow to fully meet the country's internal demand, including the guaranteed volume of free medical care, as well as to actively develop export of product, the representative of the company told Trend.
Currently the company manufactures over 240 generic drugs in 12 therapeutic groups. Furthermore, the project on manufacturing of solid dosages via method of high shear granulation is being launched by the company.
“In 2018 SANTO has supplied 64 percent in volume and 58 percent in value of realized medicine within the guaranteed volume of free medical care. Furthermore, the company is a growing exporter of medicine to Russia, Ukraine, Mongolia, Kyrgyzstan, Turkmenistan and Tajikistan,” the representative said.
Talking about the level of manufacturing digitalization, the official noted that in order to increase the digitalization level the company has launched a number of projects:
- visualization of main indicators of current condition of the venture in the form of graphs and diagrams, which will allow to base forecasts and the pattern of the venture’s conduct in the short-term and long-term future.
- the automation of planning and accounting processes on service and maintenance. Direct impact on production planning processes.
- introduction of Work Day system (cloud HR)
- serialization and aggregation (medicine marking and tracing)
“Furthermore, in summer 2019 the company has launched the first in Kazakhstan Digital Engineering And Education Center on the base of a plant in Shymkent city. The main goal of the project is the training of company’s employees in areas of IT technologies, metrology automation and technological process control. Total sumo of the investments into the project was 100 million tenge,” the representative said.
He further added that mentioned above projects will have a direct impact on manufacturing.
“For example, following the training of the staff we will decrease the number of equipment failures, accelerate maintenance work, increase the time of system performance and so on,” he concluded.
The promotional company with the trade mark SANTO is the largest pharmaceutical company in Kazakhstan and is a member of the international pharmaceutical group Polpharma, which operates in the markets of Central and Eastern Europe, The Caucasus, and Central Asia.
Follow the author on twitter: @nargiz_sadikh